Please note that until the NHS advise further on this process, while they start their due dilligence in April 2017, this does not mean immidiate implimentations of the following extract was taken from BBC News on 28/3/2017.
Source: NHS Clinical Commissioners
An initial list of 10 products has been drawn up by NHS Clinical Commissioners, which represents local health managers who are in charge of budgets.
A number of them are available over-the-counter at a lower price than the cost to the NHS of prescribing them or include drugs for which there are more effective or cheaper alternatives.
Evidence submitted to NHS England - and seen by the BBC - argues that the prescribing of gluten-free products dates back to the 1960s when there was not the choice there is now in supermarkets and shops.
Cutting back on prescriptions for the 10 products could save the NHS over £100m a year.
While patients can be charged for prescriptions, the wide range of exemptions mean only one in 10 items handed out are paid for by individuals.
'Low value' medicines on the list and their annual cost to the NHS:
- £30.93m on Liothyronine to treat underactive thyroid
- £21.88m on gluten-free foods
- £17.58m on Lidocaine plasters for treating nerve-related pain
- £10.51m on Tadalafil, an alternative to Viagra
- £10.13m on Fentanyl, a drug to treat pain in terminally ill patients
- £8.32m on the painkiller Co-proxamol
- £9.47m on travel vaccines
- £7.12m on Doxazosin MR, a drug for high blood pressure
- £6.43m on rubs and ointments
- £5.65m on omega 3 and fish oils